Suppr超能文献

PAX6介导的基因调控:错义突变体的结构-功能相关性及Trpm3/miR-204的转录调控

Gene regulation by PAX6: structural-functional correlations of missense mutants and transcriptional control of Trpm3/miR-204.

作者信息

Xie Qing, Ung Devina, Khafizov Kamil, Fiser Andras, Cvekl Ales

机构信息

Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, Bronx, NY.

Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY ; Department of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY.

出版信息

Mol Vis. 2014 Mar 6;20:270-82. eCollection 2014.

Abstract

PURPOSE

Pax6 is a key regulatory gene for eye, brain, and pancreas development. It acts as a transcriptional activator and repressor. Loss-of-function of Pax6 results in down- and upregulation of a comparable number of genes, although many are secondary targets. Recently, we found a prototype of a Pax6-binding site that acts as a transcriptional repressor. We also identified the Trpm3 gene as a Pax6-direct target containing the miR-204 gene located in intron 6. Thus, there are multiple Pax6-dependent mechanisms of transcriptional repression in the cell. More than 50 Pax6 missense mutations have been identified in humans and mice. Two of these mutations, N50K (Leca4) and R128C (Leca2), were analyzed in depth resulting in different numbers of regulated genes and different ratios of down- and upregulated targets. Thus, additional studies of these mutants are warranted to better understand the molecular mechanisms of the mutants' action.

METHODS

Mutations in PAX6 and PAX6(5a), including G18W, R26G, N50K, G64V, R128C, and R242T, were generated with site-directed mutagenesis. A panel of ten luciferase reporters driven by six copies of Pax6-binding sites representing a spectrum of sites that act as repressors, moderate activators, and strong activators were used. Two additional reporters, including the Pax6-regulated enhancer from mouse Trpm3 and six copies of its individual Pax6-binding site, were also tested in P19 cells.

RESULTS

PAX6 (N50K) acted either as a loss-of-function or neutral mutation. In contrast, PAX6 (R128C) and (R242T) acted as loss-, neutral, and gain-of-function mutations. With three distinct reporters, the PAX6 (N50K) mutation broke the pattern of effects produced by substitutions in the surrounding helices of the N-terminal region of the paired domain. All six mutations tested acted as loss-of-function using the Trpm3 Pax6-binding site.

CONCLUSIONS

These studies highlight the complexity of Pax6-dependent transcriptional activation and repression mechanisms, and identify the N50K and R128C substitutions as valuable tools for testing interactions between Pax6, Pax6 (N50K), and Pax6 (R128C) with other regulatory proteins, including chromatin remodelers.

摘要

目的

Pax6是眼睛、大脑和胰腺发育的关键调控基因。它兼具转录激活因子和抑制因子的作用。尽管许多基因是次要靶点,但Pax6功能丧失会导致数量相当的基因下调和上调。最近,我们发现了一个作为转录抑制因子的Pax6结合位点原型。我们还确定Trpm3基因是一个Pax6直接靶点,其内含子6中含有miR - 204基因。因此,细胞中存在多种Pax6依赖的转录抑制机制。在人类和小鼠中已鉴定出50多种Pax6错义突变。对其中两种突变,即N50K(Leca4)和R128C(Leca2)进行了深入分析,结果显示调控基因数量不同,下调和上调靶点的比例也不同。因此,有必要对这些突变体进行更多研究,以更好地理解突变体作用的分子机制。

方法

通过定点诱变产生PAX6和PAX6(5a)中的突变,包括G18W、R26G、N50K、G64V、R128C和R242T。使用了一组由六个Pax6结合位点拷贝驱动的十个荧光素酶报告基因,这些结合位点代表了一系列作为抑制因子、中度激活因子和强激活因子的位点。另外两个报告基因,包括来自小鼠Trpm3的Pax6调控增强子及其单个Pax6结合位点的六个拷贝,也在P19细胞中进行了测试。

结果

PAX6(N50K)表现为功能丧失或中性突变。相比之下,PAX6(R128C)和(R242T)表现为功能丧失、中性和功能获得突变。对于三个不同的报告基因,PAX6(N50K)突变打破了配对结构域N端区域周围螺旋中取代产生的效应模式。使用Trpm3 Pax6结合位点时,测试的所有六个突变都表现为功能丧失。

结论

这些研究突出了Pax6依赖的转录激活和抑制机制的复杂性,并确定N50K和R128C取代是测试Pax6、Pax6(N50K)和Pax6(R128C)与其他调控蛋白(包括染色质重塑因子)之间相互作用的有价值工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/3945805/c22e56fe6d1f/mv-v20-270-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验